Latest News

Apr 25, 2020

Glycyx MOR Inc. completes license agreement with Theravance Biopharma Inc for Axelopran

SAN FRANCISCO, April 25, 2020. Glycyx MOR Inc. a company focused on extending life in severe illness has entered into a licensing agreement with Theravance Biopharma for axelopran for development and commercialization of globally.